Global Allograft Market, By Type (DBM, Machined Allograft, Soft Tissue Allograft, and Others), Application (Dentistry, Orthopaedic, Wound Care, Spinal, Trauma, and Others), End-Users (Hospitals, Specialized Clinics, Ambulatory Surgical Centers, and Others) – Industry Trends and Forecast to 2030.
Allograft Market Regional Market Analysis and Size
The prevalence of osteoporosis, osteoarthritis, and other bone diseases among the general population is one of the major factors driving the growth of the allograft market. Increasing life expectancy and increasing incidence of lifestyle diseases, technological advancements, and growing consumer preference for minimally invasive procedures are boosting the development of the transplant market. The increase in the number of orthopedic surgeries and, among other things, the demand for surgical procedures such as shoulder surgery is driving the allograft market.
Data Bridge Market Research analyzes that the market, which was USD 670.75 million in 2022, would rocket up to USD 1083.46 million by 2030 and is expected to undergo a CAGR of 5.90% during the forecast period. The "Orthopaedic" dominates the application segment of the allograft market owing to the rise in orthopedic diseases worldwide. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Allograft Market Regional Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
By Type (DBM, Machined Allograft, Soft Tissue Allograft, and Others), Application (Dentistry, Orthopedic, Wound Care, Spinal, Trauma, and Others), End-Users (Hospitals, Specialized Clinics, Ambulatory Surgical Centers, and Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of the Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
ALLERGAN (Ireland), B. Braun Melsungen AG (Germany), CONMED Corporation (U.S.), XTANT MEDICAL (U.S.), LeMaitre Vascular, Inc. (U.S.), Alliqua (U.S.), BD (U.S.), Arthrex, Inc. (U.S.), Bone Bank Allografts (U.S.), Osiris (U.S.), Integra LifeSciences (U.S.), AlloSource (U.S.), Baxter (U.S.), DePuy Synthes (U.S.), Medtronic (Ireland), NuVasive, Inc. (U.S.), Orthofix Holdings, Inc. (U.S.), Smith & Nephew (U.K.), Stryker (U.S.), Wright Medical Group N.V. (U.S.) and Zimmer Biomet (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Allografts refer to bone or tissue known to be transplanted from one person to another with a different genotype. These bones and tissues are derived from tissues or even living donors, whether related or not, cadaveric bones. The donor specimen does not have to be a twin of the recipient, although both must be of the same species.
Global Allograft Market Dynamics
Drivers
- Increasing prevalence of chronic diseases and orthopaedic conditions
The increasing incidence of chronic diseases such as cardiovascular diseases, diabetes and orthopaedic diseases such as osteoarthritis increases the demand for allografts. Allografts are widely used in surgical procedures to replace damaged or diseased tissue, providing patients with a viable treatment option. As the world's population ages and chronic diseases continue to increase, the demand for allografts will increase significantly.
- Technological advancements in allograft processing and preservation
Improved allograft handling and storage techniques have greatly improved the safety and efficacy of allografts. Innovations such as cryopreservation, sterilization methods, and tissue banking practices have prolonged the preservation of allografts while maintaining their structural and functional integrity. These technological advances have increased the availability and availability of allografts, stimulating market growth.
- Growing preference for minimally invasive procedures
Patients and healthcare providers increasingly prefer minimally invasive procedures, which offer several advantages, including shorter recovery times, fewer post-operative complications, and better patient outcomes. Allografts are often used in minimally invasive surgeries such as arthroscopy and laparoscopy because they can be easily implanted through small incisions. The demand for allografts is expected to increase with the increased use of minimally invasive techniques.
- Increasing focus on sports medicine and sports-related injuries
Sports-related injuries such as torn ligaments, tendons, and cartilage damage are common among athletes and the general population. Allografts play a crucial role in sports medicine because they provide transplant options for reconstructive surgery and promote faster healing and tissue regeneration. The growing awareness of sports injuries and the importance of timely intervention and rehabilitation is increasing the demand for allografts in the field of sports medicine.
Opportunities
- Increasing adoption of precision medicine
Precision medicine, which involves tailoring treatment to individual patients based on their specific genetic, environmental, and lifestyle factors, represents a significant market opportunity. Allografts can play an important role in personalized medicine by providing transplant options that precisely match the patient's biological and immunological characteristics. As the field of precision medicine evolves, the demand for personalized allograft solutions is increasing, creating opportunities for companies to develop and offer customized transplant products and services.
- Growing focus on regenerative therapies
Regenerative therapies, which aim to restore or replace damaged tissues and organs, are receiving considerable attention in medicine. Allografts, especially those containing stem cells or other regenerative components, have enormous potential for regenerative medicine applications. There are opportunities for companies to invest in research and development to improve the regenerative properties of allografts, explore new delivery methods, and develop innovative combination therapies that combine allografts with other regenerative technologies.
Restraints
- Limited availability of donor tissues
The availability of donor tissues significantly limits the market for allografts. The supply of allografts is highly dependent on the availability of suitable donor tissues, which may be limited. Factors such as donor scarcity, eligibility criteria, and consent issues can limit the availability of allografts, leading to supply shortages and increased costs.
- Risk of disease transmission and graft rejection
Although strict screening and testing protocols exist to ensure the safety of allografts, there is still a tiny risk of donor-to-recipient transmission. Although this risk is minimal, it can be a concern for both patients and healthcare providers. In addition, transplant rejection, where the recipient's immune system attacks the transplanted tissue, remains a challenge that requires immunosuppressive medications and close patient monitoring.
Challenges
- Ethical and legal challenges
The use of allografts presents ethical and legal challenges related to tissue procurement, consent and allocation. Securing appropriate informed support from donors or their families, maintaining donor anonymity, and adhering to ethical guidelines can be difficult, especially in cross-border transactions. In addition, legal frameworks for tissue banking, import/export regulations, and intellectual property rights vary from country to country, presenting challenges for companies operating in the market.
- Cost and reimbursement pressures
Allografts can be expensive due to costs associated with tissue collection, processing, testing, and storage. Reimbursement policies and healthcare budget constraints can create problems in obtaining adequate reimbursement for transplant procedures, especially in public health systems. Pricing pressures and the need to demonstrate cost-effectiveness and long-term clinical benefit can create challenges for companies that can affect market entry and profitability.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market, contact Data Bridge Market Research for an Analyst Brief, our team will help you make an informed market decision to achieve market growth.
Recent Development
- In August 2022, orthopedic surgeons at University National Hospital performed the first meniscal transplant and implanted donor cartilage into the patient's knee in Scotland
- In July 2022, AlloSource added a quadricep tendon to its AlloConnex line of tendons, ligaments, and fascia. AlloSource's AlloConnex quadricep tendon is used for cruciate ligament procedures and is available with or without the bone block for various surgical techniques
Allograft Market Regional Market Scope
The market is segmented on the basis of type, application and end-users. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Demineralized bone (DBM)
- Machined allograft
- Soft tissue allograft
- Others
Application
- Dentistry
- Orthopedic
- Wound care
- Spinal
- Trauma
- Others
End User
- Hospitals
- Specialized clinics
- Ambulatory surgical centers
- Others
Global Allograft Market Regional Analysis/Insights
The market is analyzed and market size insights and trends are provided by country, type, application, and end-user as referenced above.
The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the allograft market due to the growing awareness related to the commercially accessible innovative products, well-developed healthcare structure, increasing number of trauma-related injuries and cases of orthopedic disease and higher healthcare expenditure in the region.
Asia-Pacific is expected to witness the fastest growth during the forecast period of 2023 to 2030 because of the rising medical tourism and favourable government initiatives in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points like downstream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to significant or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The market also provides detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different products for the market, impact of technology using lifeline curves, and changes in healthcare regulatory scenarios and their impact on the market. The data is available for the historic period 2010-2020.
Competitive Landscape and Market Share Analysis
The competitive market landscape provides details by competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
Some of the major players operating in the global allograftmarket are:
- ALLERGAN (Ireland)
- B. Braun Melsungen AG (Germany)
- CONMED Corporation (U.S.)
- XTANT MEDICAL (U.S.)
- LeMaitre Vascular, Inc. (U.S.)
- Alliqua (U.S.)
- BD (U.S.)
- Arthrex, Inc. (U.S.)
- Bone Bank Allografts (U.S.)
- Osiris (U.S.)
- Integra LifeSciences (U.S.)
- AlloSource (U.S.)
- Baxter (U.S.)
- DePuy Synthes (U.S.)
- Medtronic (Ireland)
- NuVasive, Inc. (U.S.)
- Orthofix Holdings, Inc. (U.S.)
- Smith & Nephew (U.K.)
- Stryker (U.S.)
- Wright Medical Group N.V. (U.S.)
- Zimmer Biomet (U.S.)
SKU-